We develop and produce our own probes, proteins and biochemistry for use in our molecular platforms.
We develop and produce our own probes, proteins and biochemistry for use in our molecular platforms. This vertical integration gives us full control over the performance, quality and cost of our diagnostic assays.
By designing our own biochemistry from the ground up, we can optimise every component for sensitivity, specificity and stability. Our in-house capabilities span probe design and synthesis, recombinant protein production, and custom reagent formulation, all tailored to work seamlessly with our molecular and lateral flow platforms.
This approach eliminates reliance on third-party suppliers for critical assay components, reducing lead times and ensuring supply chain resilience. It also enables rapid development of new assays, allowing us to respond quickly to emerging health threats and evolving diagnostic needs.